🇺🇸 FDA
Patent

US 7507407

Immunoliposomes that optimize internationalization into target cells

granted A61KA61K38/00A61K47/6849

Quick answer

US patent 7507407 (Immunoliposomes that optimize internationalization into target cells) held by The Regents of the University of California expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K47/6849, A61K47/6913, A61K9/127